坎格雷洛-话题@MedSci

#坎格雷洛#

6篇内容 | 617人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1763833, encodeId=94b01e638333c, content=<a href='/topic/show?id=e0af4142812' target=_blank style='color:#2F92EE;'>#坎格雷洛#</a>, objectTitle=Circulation：降低PCI围手术期心肌梗死事件发生率，坎格雷洛效果显著, objectType=article, longId=77291, objectId=1961e729110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1961e729110, replyNumber=0, likeNumber=31, createdTime=2017-08-02, rootId=0, userName=ms8543593053280928, userId=c98f37576020, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1961e729110, moduleTitle=Circulation：降低PCI围手术期心肌梗死事件发生率，坎格雷洛效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1961e729110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763832, encodeId=c4491e63832b5, content=<a href='/topic/show?id=e0af4142812' target=_blank style='color:#2F92EE;'>#坎格雷洛#</a>, objectTitle=Circulation：坎格雷洛对PCI术后男性vs.女性的疗效和安全性（ CHAMPION PHOENIX 研究）, objectType=article, longId=62235, objectId=62d86223572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62d86223572, replyNumber=0, likeNumber=29, createdTime=2016-11-28, rootId=0, userName=ms8543593053280928, userId=c98f37576020, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62d86223572, moduleTitle=Circulation：坎格雷洛对PCI术后男性vs.女性的疗效和安全性（ CHAMPION PHOENIX 研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62d86223572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763831, encodeId=0ac61e63831a1, content=<a href='/topic/show?id=e0af4142812' target=_blank style='color:#2F92EE;'>#坎格雷洛#</a>, objectTitle=坎格雷洛、普拉格雷、替格瑞洛：孰优？, objectType=article, longId=57693, objectId=55d55e693c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55d55e693c9, replyNumber=0, likeNumber=36, createdTime=2015-10-28, rootId=0, userName=ms8543593053280928, userId=c98f37576020, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55d55e693c9, moduleTitle=坎格雷洛、普拉格雷、替格瑞洛：孰优？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55d55e693c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763830, encodeId=25461e63830a1, content=<a href='/topic/show?id=e0af4142812' target=_blank style='color:#2F92EE;'>#坎格雷洛#</a>, objectTitle=FDA多数专家反对坎格雷洛用于减少PCI患者血栓性心血管事件, objectType=article, longId=30598, objectId=174830598cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=174830598cc, replyNumber=0, likeNumber=30, createdTime=2014-05-16, rootId=0, userName=ms8543593053280928, userId=c98f37576020, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=174830598cc, moduleTitle=FDA多数专家反对坎格雷洛用于减少PCI患者血栓性心血管事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=174830598cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763829, encodeId=08701e638296c, content=<a href='/topic/show?id=e0af4142812' target=_blank style='color:#2F92EE;'>#坎格雷洛#</a>, objectTitle=ESC 2013：CHAMPION研究分析显示坎格雷洛可降低PCI术时的血栓事件, objectType=article, longId=25374, objectId=57ad253e499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57ad253e499, replyNumber=0, likeNumber=39, createdTime=2014-06-03, rootId=0, userName=ms8543593053280928, userId=c98f37576020, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57ad253e499, moduleTitle=ESC 2013：CHAMPION研究分析显示坎格雷洛可降低PCI术时的血栓事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57ad253e499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1763828, encodeId=0c481e63828fa, content=<a href='/topic/show?id=e0af4142812' target=_blank style='color:#2F92EE;'>#坎格雷洛#</a>, objectTitle=PCI期间使用坎格雷洛可减少合并症发生（CHAMPION-PHOENIX研究）, objectType=article, longId=17864, objectId=fb431e8640c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb431e8640c, replyNumber=0, likeNumber=44, createdTime=2013-07-29, rootId=0, userName=ms8543593053280928, userId=c98f37576020, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb431e8640c, moduleTitle=PCI期间使用坎格雷洛可减少合并症发生（CHAMPION-PHOENIX研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb431e8640c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

坎格雷洛

2020-05-29

ms8543593053280928 (审核中...)

前往app查看评论内容

#坎格雷洛#

Circulation：降低PCI围手术期心肌梗死事件发生率，坎格雷洛效果显著

2017-08-02

ms8543593053280928 (审核中...)

前往app查看评论内容

#坎格雷洛#

Circulation：坎格雷洛对PCI术后男性vs.女性的疗效和安全性（ CHAMPION PHOENIX 研究）

2016-11-28

ms8543593053280928 (审核中...)

前往app查看评论内容

#坎格雷洛#

坎格雷洛、普拉格雷、替格瑞洛：孰优？

2015-10-28

ms8543593053280928 (审核中...)

前往app查看评论内容

#坎格雷洛#

FDA多数专家反对坎格雷洛用于减少PCI患者血栓性心血管事件

2014-05-16

ms8543593053280928 (审核中...)

前往app查看评论内容

#坎格雷洛#

ESC 2013：CHAMPION研究分析显示坎格雷洛可降低PCI术时的血栓事件

2014-06-03

ms8543593053280928 (审核中...)

前往app查看评论内容

#坎格雷洛#

PCI期间使用坎格雷洛可减少合并症发生（CHAMPION-PHOENIX研究）

2013-07-29

科室
- - 订阅+
  - 更多科室
工具
服务